Namara Marketplace

Top 100 prescribed drugs in Canada by rate of use, sex, age group

Sort Code

Want total control?

Request access to start using the data.

Jurisdiction

Want total control?

Request access to start using the data.

Drug Class Code

Want total control?

Request access to start using the data.

Drug Class

Want total control?

Request access to start using the data.

Age Group

Want total control?

Request access to start using the data.

Sex

Want total control?

Request access to start using the data.

Rate Of Usepercent

Want total control?

Request access to start using the data.

Number Of Active Beneficiaries

Want total control?

Request access to start using the data.

Tps In Thousands Of Dollars

Want total control?

Request access to start using the data.

Proportion Of Tpspercent

Want total control?

Request access to start using the data.

Rank

Want total control?

Request access to start using the data.

1
Canada
J01CA
Penicillins with extended spectrum
<65
F
17.4527
779345
10435.63
0.3422
1
1
Canada
N06AB
Selective serotonin reuptake inhibitors
<65
F
13.065
583414
55823.09
1.8305
2
1
Canada
R03AC
Selective beta-2-adrenoreceptor agonists
<65
F
12.1481
542470
15850.83
0.5198
3
1
Canada
M01AE
Propionic acid derivatives
<65
F
11.2439
502091
10897.93
0.3573
4
1
Canada
G03AA
Progestogens and estrogens, fixed combinations
<65
F
11.2135
500734
27606.37
0.9052
5
1
Canada
A02BC
Proton pump inhibitors
<65
F
11.1179
496463
39701.62
1.3018
6
1
Canada
N06AX
Other antidepressants
<65
F
9.5058
424478
63391.02
2.0786
7
1
Canada
J01FA
Macrolides
<65
F
9.2022
410920
6592.38
0.2162
8
1
Canada
H03AA
Thyroid hormones
<65
F
7.9832
356488
17755.65
0.5822
9
1
Canada
D07AC
Corticosteroids, potent (group III)
<65
F
7.5277
336148
6511.13
0.2135
10
1
Canada
C10AA
HMG-CoA reductase inhibitors
<65
F
7.2655
324440
25885.61
0.8488
11
1
Canada
N02AJ
Opioids in combination with non-opioid analgesics
<65
F
7.1438
319002
15298.01
0.5016
12
1
Canada
H02AB
Glucocorticoids
<65
F
6.4489
287971
5535.68
0.1815
13
1
Canada
N05BA
Benzodiazepine derivatives
<65
F
6.4402
287583
15453.9
0.5067
14
1
Canada
R01AD
Corticosteroids
<65
F
6.3531
283696
9807.82
0.3216
15
1
Canada
R03BA
Glucocorticoids
<65
F
6.1708
275555
30058.97
0.9857
16
1
Canada
J01DB
First-generation cephalosporins
<65
F
5.807
259310
5843.04
0.1916
17
1
Canada
J01XE
Nitrofuran derivatives
<65
F
5.7191
255382
3043.71
0.0998
18
1
Canada
N03AX
Other antiepileptics
<65
F
5.4458
243179
58199.66
1.9084
19
1
Canada
N02BE
Anilides
<65
F
5.0832
226988
6981.75
0.2289
20
1
Canada
J01CR
Combinations of penicillins, including beta-lactamase inhibitors
<65
F
4.8977
218703
4077.55
0.1337
21
1
Canada
C09AA
ACE inhibitors, plain
<65
F
4.2079
187903
13234.55
0.434
22
1
Canada
M03BX
Other centrally acting agents
<65
F
4.1566
185612
8428.98
0.2764
23
1
Canada
J05AB
Nucleosides and nucleotides, excluding reverse transcriptase inhibitors
<65
F
4.1343
184617
7386.77
0.2422
24
1
Canada
J01MA
Fluoroquinolones
<65
F
4.0807
182221
2944.46
0.0966
25
1
Canada
D06AX
Other antibiotics for topical use
<65
F
4.01
179065
5164.56
0.1693
26
1
Canada
A11CC
Vitamin D and analogues
<65
F
4.0042
178807
10349.87
0.3394
27
1
Canada
A10BA
Biguanides
<65
F
3.9842
177913
10342.88
0.3391
28
1
Canada
N05AH
Diazepines, oxazepines, thiazepines and oxepines
<65
F
3.9605
176856
51788.91
1.6982
29
1
Canada
N02AA
Natural opium alkaloids
<65
F
3.8604
172384
43791.51
1.4359
30
1
Canada
J01AA
Tetracyclines
<65
F
3.6835
164483
3134
0.1028
31
1
Canada
J07BB
Influenza vaccines
<65
F
3.2994
147334
1154.48
0.0379
32
1
Canada
C08CA
Dihydropyridine derivatives
<65
F
3.2619
145661
11594.73
0.3802
33
1
Canada
P01AB
Nitroimidazole derivatives
<65
F
3.2528
145251
1641.38
0.0538
34
1
Canada
D07AA
Corticosteroids, weak (group I)
<65
F
3.187
142312
2477.73
0.0812
35
1
Canada
N06AA
Non-selective monoamine reuptake inhibitors
<65
F
3.1747
141767
12600.78
0.4132
36
1
Canada
G03AB
Progestogens and estrogens, sequential preparations
<65
F
**
**
**
**
37
1
Canada
G03CA
Natural and semisynthetic estrogens, plain
<65
F
2.8826
128723
10145.37
0.3327
38
1
Canada
B03AA
Iron bivalent, oral preparations
<65
F
2.8587
127656
5937.24
0.1947
39
1
Canada
N06BA
Centrally acting sympathomimetics
<65
F
2.7436
122516
54693.73
1.7934
40
1
Canada
A02BA
H2-receptor antagonists
<65
F
2.6057
116355
5415.94
0.1776
41
1
Canada
J01EE
Combinations of sulfonamides and trimethoprim, including derivatives
<65
F
2.5476
113762
1451.57
0.0476
42
1
Canada
R03AK
Adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics
<65
F
2.5214
112593
47763.01
1.5662
43
1
Canada
C07AB
Beta-blocking agents, selective
<65
F
2.4688
110245
7233.97
0.2372
44
1
Canada
N03AE
Benzodiazepine derivatives
<65
F
2.4429
109085
11524.73
0.3779
45
1
Canada
C09CA
Angiotensin II receptor blockers (ARBs), plain
<65
F
2.3926
106842
9103.75
0.2985
46
1
Canada
G03AC
Progestogens
<65
F
2.3923
106825
6605.73
0.2166
47
1
Canada
J01FF
Lincosamides
<65
F
2.1657
96709
1901.81
0.0624
48
1
Canada
M01AB
Acetic acid derivatives and related substances
<65
F
2.1566
96302
3484.81
0.1143
49
1
Canada
J02AC
Triazole derivatives
<65
F
2.0967
93628
5196.04
0.1704
50

Want to start using the data?

Namara offers a connection to over 250K data feeds from every industry and the tools to drive value and insight.